Filing Details
- Accession Number:
- 0001209191-13-048944
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-10-22 17:28:45
- Reporting Period:
- 2013-10-18
- Filing Date:
- 2013-10-22
- Accepted Time:
- 2013-10-22 17:28:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1333170 | Nxstage Medical Inc. | NXTM | Electromedical & Electrotherapeutic Apparatus (3845) | 043454702 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1382096 | S. Robert Brown | C/O Nxstage Medical, Inc. 350 Merrimack Street Lawrence MA 01843 | President, Kidney Care | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-10-18 | 64,791 | $8.92 | 97,313 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-10-18 | 64,791 | $14.00 | 32,522 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-10-21 | 75,309 | $8.92 | 107,831 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-10-21 | 75,309 | $14.00 | 32,522 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2013-10-18 | 64,791 | $0.00 | 64,791 | $8.92 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2013-10-21 | 75,309 | $0.00 | 75,309 | $8.92 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
75,309 | 2007-11-27 | 2013-11-26 | No | 4 | M | Direct |
0 | 2007-11-27 | 2013-11-26 | No | 4 | M | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2013.
- The option vested as to 25% of the underlying shares on the first anniversary of the grant date and in equal monthly installments over the following 36 months.